CARM: Carisma Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Steven Kelly

Headquarters

3675 MARKET STREET,SUITE 200
PHILADELPHIA, PA 19104, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

Carisma Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

17.47M

Enterprise Value

10.37M

Enterprise Value/EBITDA(ttm)

-0.21

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.95

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-314.78%

Profit Margin(ttm)

-306.96%

Return on Equity(ttm)

-957.20%

Return on Invested Capital(ttm)

-1091.23%

Return on Assets(ttm)

-96.39%

Income Statement

Revenue(ttm)

19.96M

Revenue Per Share(ttm)

0.48

Gross Profit(ttm)

19.96M

EBITDA(ttm)³

-49.68M

Net Income Available to Common(ttm)

-50.77M

Diluted EPS(ttm)

-1.56

Share Statistics

Beta (5Y Monthly)

1.56

52-Week Change

-60.39%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

41.79M

Dividend Yield

0.00%

Float⁴

36.50M

% Held by Insiders

12.57%

% Held by Institutions

44.27%

Balance Sheet

Total Cash(mrq)

7.74M

Total Cash Per Share(mrq)

0.19

Total Debt(mrq)

640.00K

Total Debt/Equity(mrq)

-1.75%

Current Ratio(mrq)

1.34%

Quick Ratio(mrq)

3.23%

Book Value Per Share(mrq)

-0.88

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.24

Free Cash Flow(ytd)

-9.54M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CARM

Carisma Therapeutics, Inc. Common Stock

Carisma Therapeutics, Inc. Common Stock Profile